International collaboration

At the Danish National Genome Center (DNGC), we are constantly taking inspiration from projects and experiences from genome initiatives around the world to ensure that our software solutions and infrastructure are state-of-the-art

International projects

DNGC represents Denmark in the European 1+ Million Genomes (1+MG) Initiative, which originated in 2018. The aim of the initiative is to enable secure access to genome data across Europe. Genome data should be accessible across borders, but without data being sent out of the individual countries. Analysis must be carried out locally, and the results will subsequently be merged. The focus is on disease prevention, diagnostics, personalised medicine and research.

DNGC is also participating in the Genomic Data Infrastructure project (GDI), which is part of the 1+MG initiative. The project aims to ensure the establishment of a secure and sustainable federated data infrastructure where metadata is exhibited on a common European platform, and where data can be accessed and analyzed within each country's borders. Only the results of the analysis can be transmitted outside the country of origin. The project involves genomic data and clinical data from databases across Europe, focusing on cancer, infectious diseases, and rare diseases, among other aspects. The project is funded by EU and the participating countries.

The Genome of Europe (GoE) project is also a part of the implementation of the 1+MG initiative. The aim of the GoE is to build a network of genomic reference cohorts across the population of Europe. The intention is to initially include at least 100,000 people from across Europe, and in the long term include up to 500,00 people.

Bilateral collaboration

Several countries share DNGC’s ambition of building and operating a genomic infrastructure for developing personalized medicine. The Danish National Genome Center is cooperating with several European countries in order to share experiences and exchange knowledge about e.g. research, data analyses, clinical outputs, and bioinformatic issues within genomic medicine.

The National Genome Center collaborates closely with Sweden (Genomic Medicine Sweden), England (Genomics England), and France (The France Genomic Medicine Plan 2025) on implementation of genomic medicine in the healthcare system. We also have ongoing dialogue with several other countries to ensure knowledge sharing across borders.

The bilateral collaborations help to ensure fast and successful progress through joint strategic approaches to how genomic medicine can be implemented in the healthcare system optimally.

Read more about our European collaboration partners